Preclinical Application of CEST MRI to Detect Early and Regional Tumor Response to Local Brain Tumor Treatment
Treating glioblastoma and monitoring treatment response non-invasively remain challenging. Here, we developed a robust approach using a drug-loaded liposomal hydrogel that is mechanically compatible with the brain, and, simultaneously, we successfully monitored early tumor response using Chemical Ex...
Main Authors: | Se-Weon Park, Joseph H. C. Lai, Xiongqi Han, Vivian W. M. Leung, Peng Xiao, Jianpan Huang, Kannie W. Y. Chan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/16/1/101 |
Similar Items
-
Molecular Imaging of Brain Tumors and Drug Delivery Using CEST MRI: Promises and Challenges
by: Jianpan Huang, et al.
Published: (2022-02-01) -
The Value of APTw CEST MRI in Routine Clinical Assessment of Human Brain Tumor Patients at 3T
by: Julia P. Lingl, et al.
Published: (2022-02-01) -
Mapping of Absolute Host Concentration and Exchange Kinetics of Xenon Hyper-CEST MRI Agents
by: Martin Kunth, et al.
Published: (2021-01-01) -
Optimized CEST cardiovascular magnetic resonance for assessment of metabolic activity in the heart
by: Zhengwei Zhou, et al.
Published: (2017-11-01) -
Non-invasive Investigation of Tumor Metabolism and Acidosis by MRI-CEST Imaging
by: Lorena Consolino, et al.
Published: (2020-02-01)